Vitamin D group (N = 35) | Placebo group (N = 33) | ||
---|---|---|---|
Females | N (%) | 24 (69) | 24 (73) |
Age (years) | Mean (range) | 40 (21–50) | 41 (26–50) |
Body mass index | Mean (range) | 25.9 (21.0–40.7) | 26.4 (18.4–39.9) |
Ongoing smoking | N (%) | 15 (43) | 14 (42) |
EDSS | Median (range) | 2.5 (0–4.5) | 2.0 (0–4.5) |
Annualised relapse rate | Mean (range) | 0.11 (0–0.54) | 0.15 (0–1.10) |
Immunomodulatory treatment | N (%) | 17 (49)a | 17 (52)b |
Serum 25(OH)D (nmol/L) | Mean (SD) | 55.6 (29.0) | 57.3 (21.8) |
Hip BMD (mg/cm2) | Mean (SD) | 1018.8 (98.8) | 968.9 (119.9) |
Spine BMD (mg/cm2) | Mean (SD) | 1205.2 (117.7) | 1165.7 (135.6) |
Distal radius BMD (mg/cm2) | Mean (SD) | 484.8 (67.1) | 472.8 (80.6) |